argenx SE (EBR:ARGX)
Belgium · Delayed Price · Currency is EUR 646.60
-10.80 (-1.64%)
Mar 2, 2026, 2:45 PM CET
argenx SE Market Cap
argenx SE has a market cap or net worth of €40.23 billion as of March 2, 2026. Its market cap has increased by 7.04% in one year.
Market Cap
40.23B
Enterprise Value
36.49B
Revenue
3.62B
Ranking
n/a
PE Ratio
39.44
Stock Price
€646.60
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 122.42M to 40.23B, an increase of 32,764.19%. That is a compound annual growth rate of 64.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 40.23B | -8.29% |
| Dec 31, 2025 | 43.87B | 21.11% |
| Dec 31, 2024 | 36.22B | 78.48% |
| Dec 29, 2023 | 20.29B | 5.32% |
| Dec 30, 2022 | 19.27B | 18.28% |
| Dec 31, 2021 | 16.29B | 42.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 48.03B |
| Financière de Tubize | 10.08B |
| Onward Medical | 235.24M |
| Hyloris Pharmaceuticals | 199.92M |
| European Medical Solutions | 23.02M |
| Celyad Oncology | 17.46M |
| BioSenic | 1.63M |
| Oxurion NV | 392.55K |